PharmaResearch Co., Ltd. Logo

PharmaResearch Co., Ltd.

Develops regenerative medicine, devices & cosmetics using marine biotechnology.

214450 | KO

Overview

Corporate Details

ISIN(s):
KR7214450009
LEI:
Country:
South Korea
Address:
강원도 강릉시 과학단지로 77-19, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaResearch Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. It develops, produces, and sells a range of products including pharmaceuticals, medical devices, and cosmetics. The company's core technology leverages marine biotechnology to create refined raw materials for cell and tissue regeneration. In addition to its product lines, PharmaResearch also offers consulting services for the development, licensing, and registration of medical products. The company is dedicated to enhancing human health through its innovative regenerative solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-21 00:00
Regulatory News Service
불성실공시법인미지정 (지정유예)
Korean 5.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.3 MB
2025-08-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.7 KB
2025-08-01 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.0 KB
2025-07-31 00:00
Regulatory News Service
불성실공시법인지정예고 (공시번복)
Korean 4.9 KB
2025-07-08 00:00
M&A Activity
기타주요경영사항 (회사분할결정 철회)
Korean 3.4 KB
2025-07-08 00:00
M&A Activity
[기재정정]주요사항보고서(회사분할결정)
Korean 27.3 KB
2025-07-08 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 9.8 KB
2025-06-27 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 13.9 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-16 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-13 00:00
Delisting Announcement
주권매매거래정지 (분할)
Korean 4.9 KB
2025-06-13 00:00
M&A Activity
주요사항보고서(회사분할결정)
Korean 49.2 KB

Automate Your Workflow. Get a real-time feed of all PharmaResearch Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmaResearch Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmaResearch Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Oncopeptides Logo
Develops targeted therapies for hematological cancers using peptide-drug conjugate technology.
Sweden
ONCO
Onesano S.A. Logo
Develops patented nutritional products for humans, animals, and agriculture.
Poland
SKT
OnKure Therapeutics, Inc. Logo
Developing less toxic, tumor-agnostic kinase inhibitors for precision cancer therapy.
United States of America
OKUR
ONO PHARMACEUTICAL CO., LTD. Logo
Develops innovative medicines for high unmet needs in oncology, immunology, and neurology.
Japan
4528
OPKO Health Inc. Logo
Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.
Israel
OPK
OPKO HEALTH, INC. Logo
A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.
United States of America
OPK
Opthea Ltd Logo
Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.
United States of America
OPT
OPTUS Pharmaceutical Co., Ltd. Logo
Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.
South Korea
131030
Opus Genetics, Inc. Logo
Developing gene therapies for inherited retinal diseases and other blinding conditions.
United States of America
IRD
ORAGENICS INC Logo
Biotech developing intranasal drugs for concussion and other brain disorders.
United States of America
OGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.